Rapid or significant weight loss itself may affect eligibility
This common question arises among patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
The organization declared another shortage in September 2023, which saw blood supply levels drop by 25%
compounded semaglutide commonly priced $150, $400/month depending on dose Accreditation / PCAB accreditation status should be verified directly on the PCAB registry before dispensing Key risk / FDA has flagged compounded GLP-1s under shortage-list criteria
This single-receptor activation slows gastric emptying, reduces appetite signaling in the brain, improves insulin sensitivity, and creates a sustained feeling of fullness that makes caloric restriction feel almost effortless for many users
In clinical practice, steady and sustainable weight loss is usually a better predictor of long-term success than rapid changes over a short period of time. Semaglutide vs Tirzepatide Timeline Chart Individual results vary significantly
